Ahsan Majid, Jánosi Rolf Alexander, Rassaf Tienush, Lind Alexander
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Eur Heart J Case Rep. 2021 Jan 15;5(1):ytaa567. doi: 10.1093/ehjcr/ytaa567. eCollection 2021 Jan.
Patients with severe aortic stenosis (AS) often present with multiple comorbidities and suffer from critical coronary artery disease (CAD). Transcatheter aortic valve replacement (TAVR) has become the therapy of choice for moderate to high-risk patients. Venoarterial extracorporeal membrane oxygenation (v-a-ECMO) offers the possibility of temporary cardiac support to manage life-threatening critical situations.
Here, we describe the management of a patient with severe AS and CAD with impaired left ventricular ejection fraction (LVEF). We used v-a-ECMO as an emergency strategy in cardiogenic shock during a high-risk coronary intervention to stabilize the patient, and as a further bridge to TAVR.
Very high-risk patients with severe AS are unlikely to tolerate the added risk of surgical aortic valve replacement. Using ECMO may help them to benefit from TAVR as the only treatment option available.
重度主动脉瓣狭窄(AS)患者常伴有多种合并症,且患有严重冠状动脉疾病(CAD)。经导管主动脉瓣置换术(TAVR)已成为中高危患者的首选治疗方法。静脉-动脉体外膜肺氧合(v-a-ECMO)为处理危及生命的危急情况提供了临时心脏支持的可能性。
在此,我们描述了一名患有重度AS和CAD且左心室射血分数(LVEF)受损患者的治疗情况。我们在高危冠状动脉介入治疗期间将v-a-ECMO作为心源性休克的紧急策略以稳定患者病情,并作为进一步过渡到TAVR的桥梁。
重度AS的极高危患者不太可能耐受外科主动脉瓣置换术增加的风险。使用ECMO可能有助于他们受益于TAVR这一唯一可用的治疗选择。